Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTanta University
About this trial
This prospective randomized double blinded study will be conducted to evaluate the effect of early pharmacologic intervention with calcitonin on the incidence or the severity of neuropathic pain after spinal cord injury
Eligibility criteria
Qualifiers
Patients aged ≥18 years, with spinal cord injury at any level and any degree of completeness in the early stage of trauma.
Disqualifiers
Intake of anticonvulsants medications.
Evidence of neuropathic pain.
Evidence of previous allergic reaction to calcitonin.
Patients with renal, hepatic and cardiac dysfunction or neurological disorders .
Trial design
Treatments tested in this trial
- Calcitonin
- Placebo
Treatment groups
126 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov